Nursing Students Education Virtual Reality Wound Care
Launched by ANKARA MEDIPOL UNIVERSITY · Mar 20, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how effective virtual reality (VR) training can be in teaching nursing students about preventing pressure sores, which are injuries to the skin caused by prolonged pressure. The study will involve 66 second-year nursing students from a foundation university. Some students will learn through VR goggles, while others will use written materials. The researchers want to see if VR training increases student satisfaction, confidence, and knowledge about wound care.
To participate, students must be in their second year of nursing school. Those in their first, third, or fourth years will not be eligible. Throughout the study, participants will take tests before and after their training to measure how much they’ve learned. The study aims to show if VR can help nursing students better understand how to prevent pressure sores, which is important for both patient care and reducing healthcare costs. The researchers will handle the data carefully and keep it safe for five years before it is destroyed.
Gender
ALL
Eligibility criteria
- • İnclusion Criteria
- • Nursing Students,
- • 2nd year nursing student
- • Exclusion Criteria
- • not a nursing student
- • 1st, 3rd or 4th year nursing student
About Ankara Medipol University
Ankara Medipol University is a distinguished academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge medical education and scientific inquiry to enhance patient care and treatment outcomes. Our commitment to ethical research practices and adherence to regulatory standards ensures the integrity and reliability of our clinical trials, contributing to the global body of medical knowledge and fostering the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported